Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
Published on: August 11, 2023
Non-pharmacologic approaches to treatment of pediatric functional abdominal pain disorders
Partha Sarathi Chakraborty1, Rhea Daniel1, Fernando A Navarro1
1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, United States.
Insights
Functional abdominal pain disorders (FAPDs) in children are linked to brain-gut interactions. This review explores non-pharmacologic treatments like diet, microbiome manipulation, and psychological therapies for FAPDs.
Area of Science:
- Pediatric Gastroenterology
- Neurogastroenterology
- Brain-Gut Interactions
Background:
- Functional abdominal pain disorders (FAPDs) affect up to 25% of US children.
- FAPDs are increasingly understood as disorders of brain-gut interaction.
- Pathophysiology involves gut motility, visceral hypersensitivity, microbiome dysbiosis, and psychological factors.
Purpose of the Study:
- To review non-pharmacologic interventions for FAPDs in children.
- To summarize dietary, microbiome-based, and psychological treatment approaches.
- To highlight the need for evidence-based research on these therapies.
Main Methods:
- Literature review of non-pharmacologic treatments for FAPDs.
- Categorization of interventions into dietary, microbiome manipulation, and psychological approaches.
- Inclusion of data from a survey on complementary and alternative medicine use.
Main Results:
- Non-pharmacologic strategies include dietary changes, microbiome modulation (probiotics, prebiotics, FMT), and psychological therapies (CBT, hypnotherapy).
- A significant majority (96%) of patients utilize complementary and alternative medicine.
- Limited data exists to support the efficacy of many reviewed therapies.
Conclusions:
- Non-pharmacologic interventions offer potential treatment avenues for pediatric FAPDs.
- Further large-scale randomized controlled trials are essential to establish efficacy and guide clinical practice.
- Addressing brain-gut axis components is crucial for managing FAPDs.
Abstract:
Functional abdominal pain disorders (FAPDs) affect up to 25% of children in the United States. These disorders are more recently known as disorders of "brain-gut" interaction. The diagnosis is based on the ROME IV criteria, and requires the absence of an organic condition to explain the symptoms. Although these disorders are not completely understood, several factors have been involved in the pathophysiology including disordered gut motility, visceral hypersensitivity, allergies, anxiety/stress, gastrointestinal infection/inflammation, as well dysbiosis of the gut microbiome. The pharmacologic and non-pharmacologic treatments for FAPDs are directed to modifying these pathophysiologic mechanisms. This review aims to summarize the non-pharmacologic interventions used in the treatment of FAPDs including dietary modifications, manipulation of the gut microbiome (neutraceuticals, prebiotics, probiotics, synbiotics and fecal microbiota transplant) and psychological interventions that addresses the "brain" component of the brain-gut axis (cognitive behavioral therapy, hypnotherapy, breathing and relaxation techniques). In a survey conducted at a large academic pediatric gastroenterology center, 96% of patients with functional pain disorders reported using at least 1 complementary and alternative medicine treatment to ameliorate symptoms. The paucity of data supporting most of the therapies discussed in this review underscores the need for large randomized controlled trials to assess their efficacy and superiority compared to other treatments.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

